EHR and ICD-10 Convergence: Using a Synergistic Approach

ICD-10 and Meaningful Use Webinar – Synergies, Workflows Risks and Opportunities

 

Context and Learning Objectives

  • The recent CMS / AMA announcement on ICD-10 implementation; who is now eligible for a reprieve on their ICD-10 completion date; and what it means for certain providers, health IT companies and payers
  • The 10+ Meaningful Use Stage 2 measures and 20+ EHR clinical processes impacted by ICD-10
  • How structured discrete data for problem lists can support ICD-10
  • The clinician knowledge management crisis – overflows of data instantiate a need for specialized data ontologies and interoperable patient data to guide physician clinical documentation in EHRs to support ICD-10
  • Best practices your organization should be using right now

About the Speaker

Michael Arrigo is Managing Partner of No World Borders, a healthcare information technology and regulatory consulting group. He has provided expert testimony in cases before the Federal Trade Commission in Washington, D.C., and in State Court in California, Oregon, Washington, Texas, Michigan and Florida. He and his team advise healthcare organizations and investors regarding healthcare-related regulations, including medical records clinical documentation, coding and billing, the International Classification of Diseases version 10 (ICD-10), and the Health Information Technology for Economic and Clinical Health Act (HITECH Act). He also advises healthcare organizations regarding healthcare claims reimbursement and coverage determination provisions of the Patient Protection and Affordable Care Act of 2010. Mr. Arrigo previously worked for Silicon Valley companies including Oracle, HP Symantec and Intel, and served as Senior Vice President of eCommerce for Fidelity and CoreLogic.

Related Posts

Affordable Care Act Expert Witness

Michael F. Arrigo

Michael Arrigo brings four decades of experience in the software, financial services, and healthcare industries. In 2000, Mr. Arrigo founded No World Borders, a healthcare data, regulations, and economics firm with clients in the pharmaceutical, medical device, hospital, surgical center, physician group, diagnostic imaging, genetic testing, health IT, and health insurance markets. His expertise spans the federal health programs Medicare and Medicaid and private insurance. He advises Medicare Advantage Organizations who provide health insurance under Part C of the Medicare Act. Mr. Arrigo serves as an expert witness regarding medical coding and medical billing, fraud damages, as well as electronic health record software for the U.S. Department of Justice. He has valued well over $1 billion in medical billings in personal injury liens, medical malpractice, insurance fraud cases. The U.S. Court of Appeals considered Mr. Arrigo's opinion regarding loss amounts, vacating, and remanding sentencing in a fraud case. Mr. Arrigo provides expertise in the Medicare Secondary Payer Act, Medicare LCDs, anti-trust litigation, medical intellectual property and trade secrets, HIPAA privacy, health care electronic claim data Standards, physician compensation, Anti-Kickback Statute, Stark law, the Affordable Care Act, False Claims Act, and the ARRA HITECH Act. Arrigo advises investors on merger and acquisition (M&A) diligence in the healthcare industry on transactions cumulatively valued at over $1 billion. Mr. Arrigo spent over ten years in Silicon Valley software firms in roles from Product Manager to CEO. He was product manager for a leading-edge database technology joint venture that became commercialized as Microsoft SQL Server, Vice President of Marketing for a software company when it grew from under $2 million in revenue to a $50 million acquisition by a company now merged into Cincom Systems, hired by private equity investors to serve as Vice President of Marketing for a secure email software company until its acquisition and multi $million investor exit by a company now merged into Axway Software SA (Euronext: AXW.PA), and CEO of one of the first cloud-based billing software companies, licensing its technology to Citrix Systems (NASDAQ: CTXS). Later, before entering the healthcare industry, he joined Fortune 500 company Fidelity National Financial (NYSE: FNF) as a Vice President, overseeing eCommerce solutions for the mortgage banking industry. While serving as a Vice President at Fortune 500 company First American Financial (NYSE: FAF), he oversaw eCommerce and regulatory compliance technology initiatives for top ten mortgage banks and led the Sarbanes Oxley Act Section 302 internal controls IT audit for the company, supporting Section 404 of the Sarbanes Oxley Act. Mr. Arrigo earned his Bachelor of Science in Business Administration from the University of Southern California. Before that, he studied computer science, statistics, and economics at the University of California, Irvine. His post-graduate studies include biomedical ethics at Harvard Medical School, biomedical informatics at Stanford Medical School, blockchain and crypto economics at the Massachusetts Institute of Technology, and training as a Certified Professional Medical Auditor (CPMA). Mr. Arrigo is qualified to serve as a director due to his experience in healthcare data, regulations, and economics, his leadership roles in software and financial services public companies, and his healthcare M&A diligence and public company regulatory experience. Mr. Arrigo is quoted in The Wall Street Journal, Fortune Magazine, Kaiser Health News, Consumer Affairs, National Public Radio (NPR), NBC News Houston, USA Today / Milwaukee Journal Sentinel, Medical Economics, Capitol ForumThe Daily Beast, the Lund Report, Inside Higher Ed, New England Psychologist, and other press and media outlets. He authored a peer-reviewed article regarding clinical documentation quality to support accurate medical coding, billing, and good patient care, published by Healthcare Financial Management Association (HFMA) and is published in Healthcare IT News.

Leave a Reply